Skip to content
October 1, 2026
  • Home
  • About us
  • Contact us
  • Newsletter
  • Privacy Policy
Political Economist

Political Economist

A liberal News reporting Politics, Sports, Business, Commentaries

  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
  • Business & Economy
  • Politics
Watch Online
  • Home
  • Business & Economy
  • BUHARI DIRECTS HEALTH MINISTER TO SUBMIT PROGRESS REPORT ON LOCAL VACCINE PRODUCTION IN MAY
  • Business & Economy

BUHARI DIRECTS HEALTH MINISTER TO SUBMIT PROGRESS REPORT ON LOCAL VACCINE PRODUCTION IN MAY

Admin April 21, 2022
vaccines

COVID-19: Race for vaccine

April 21, 2022

President Muhammadu Buhari on Wednesday in Abuja directed the Minister of Health, Dr. Osagie Ehanire, to submit a progress report by the end of May 2022 on the indigenous production of vaccines in the country.

In a statement by a residential spokesperson, Femi Adesina, the President gave the directive while receiving the leadership of the Nigeria Integrated Biopharmaceuticals Industries Consortium (NIBI), led by Mr. Vilarugel Cuyas, Chairman/Chief Executive Officer of Fredlab.

The President commended the NIBI consortium made up of European biotechnology companies Merck, Unizima, Rommelag, and Fredlab, who are collaborating with the Nigerian start-up PIA BioPharma to establish a world-class Bio-Pharma Industrial Complex for the manufacture of vaccines and essential therapeutics in Nigeria.

Stressing that this administration considers food and medicine sufficiency as national security issues, the President asked the health minister and his team to work closely with the consortium on the Federal Government support required for the actualization of the NIBI project within the next few months.

‘‘While the Ministry of Health continues to drive collaboration with investors for vaccines, pharmaceuticals, and medical devices, in a move towards self-sufficiency, I welcome the NIBI consortium’s desire to partner with the Federal Government in support of our agenda and look forward to the implementation of the NIBI project as it takes shape,’’ the President said.

Recounting the impact of COVID-19 pandemic on Nigeria’s economy and health systems and how some nations with comparative advantages in being centres of bio-pharmaceutical productions adopted a “me-first” attitude towards securing their citizens, President Buhari said:

‘‘I want Nigeria to make a bold statement in this field not just for reasons mentioned earlier, but because of its knock-on effects on our economy at large.’’

The President told his audience that Nigeria has learnt key lessons from the pandemic, including that countries must look inward for sustenance in food and medical supplies.

‘‘Having witnessed the impact of the COVID-19 pandemic on our health system, our communal life and national economy, from which we are yet to fully recover, we are reminded that the wealth of a nation is dependent on the health and wellbeing of its citizens.

‘‘ At the advent of the COVID-19 pandemic, Nigeria was quick to respond to what seemed an existential threat, by strengthening the health system’s capacity to handle the pandemic – an initiative that continues till today in collaboration with the state government, private sector, and international partners.

‘‘Key lessons of the pandemic are that nations can be brought to their knees by disease outbreaks that cripple national and international trade, and that countries must be able to look inwards for sustenance in food and medical supplies. The benefit of this Administration’s early investment in agriculture came to light during this global turbulence.

‘‘However, we cannot say the same for essential medicines, health supplies and most importantly vaccines to protect our citizens. Increasing the capacity for in-country production of vaccines and medical supplies has therefore become a matter of not just urgency, but of national security.

‘‘As we saw, many nations who had developed comparative advantages in being centres of bio-pharmaceutical productions adopted a “me-first” attitude towards securing their citizens. These actions placed developing nations, particularly those in Africa at severe disadvantage.’’

The President noted that as part of the fallout and lessons learned from the crises, under his directive, the Minister of Health has been conducting local and international high-level consultations to seek access to the know-how and finance to revive domestic manufacturing of vaccines.

He added that the consultations had become more important as Nigeria prepares to fully transition from the Global Alliance for Vaccines and Immunization (GAVI) support for the supply of vaccines by 2028.

‘‘Since we consider food and medicine sufficiency as national security issues, technical and financial investments and partnerships are priorities in our policy planning, with the assurance that Nigeria has the market and a pool of expert scientists to draw upon, from within and outside the country,’’ he said.

  • Facebook
  • Share on X
  • LinkedIn
  • WhatsApp
  • Email
  • Copy Link
Tags: Biopharma GAVI Mr. Vilarugel Muhammadu Buhari NIBI Osagie Ehanire

Post navigation

Previous Dariye, Nyame pardon will not derail anti-corruption war – Presidency assures Nigerians
Next 2023: Again, PDP extends sale of nomination forms

Related Stories

Honeywell to help build Dangote’s new Kenyan mega-refinery William Ruto
  • Business & Economy

Honeywell to help build Dangote’s new Kenyan mega-refinery

September 30, 2026
Dangote to begin construction of $16 billion East Africa refinery in Kenya Aliko Dangote
  • Business & Economy

Dangote to begin construction of $16 billion East Africa refinery in Kenya

September 30, 2026
NGX Group Chairman Woos East African Investors for Upcoming Dangote Refinery IPO
  • Business & Economy
  • National News

NGX Group Chairman Woos East African Investors for Upcoming Dangote Refinery IPO

September 29, 2026
logo

Political Economist is a liberal news magazine with global affiliations.

At Political Economist, we promote free enterprise and act as a catalyst for the growth of knowledge economy. We are proudly pan-Nigeria yet richly spiced with African and global news. We offer a fair and balanced news reportage presented by our team of well-heeled professional journalists. <

About us

  • 5 Olutosin Ajayi Street, By CPM Church, Ajao Estate, Lagos State, Nigeria
  • +234 805 680 1124
  • info@politicaleconomistng.com

Follow

Subscribe to notifications

You may have missed

Drug Abuse Accounts for 50% of Psychiatric Cases, Says Kaduna Neuro-Psychiatric Hospital Boss daily doses
  • National News

Drug Abuse Accounts for 50% of Psychiatric Cases, Says Kaduna Neuro-Psychiatric Hospital Boss

September 30, 2026
Cyber-Fraud: EFCC Secures Final Forfeiture of 431 Phones from Chinese Convicts Scammers
  • metro

Cyber-Fraud: EFCC Secures Final Forfeiture of 431 Phones from Chinese Convicts

September 30, 2026
Military neutralises 554 terrorists, criminals, arrests 1,333 in Q3 – DHQ onyeuko
  • National News

Military neutralises 554 terrorists, criminals, arrests 1,333 in Q3 – DHQ

September 30, 2026
Alleged fake agency: Court remands Adeniyi Adeyemi in Kuje Correctional Centre
  • National News

Alleged fake agency: Court remands Adeniyi Adeyemi in Kuje Correctional Centre

September 30, 2026
  • Home
  • About us
  • Contact us
  • Newsletter
  • Privacy Policy
Copyright © All rights reserved. | DarkNews by AF themes.